Invitae Wants Myriad's Gene-Testing Patent Suit Tossed

Law360, New York (December 10, 2013, 10:28 PM EST) -- Genetic testing company Invitae Corp. asked a Utah federal court Monday to throw out Myriad Genetics Inc.’s suit alleging Invitae infringed on its patents relating to genetic screening for breast cancer, saying the court lacks jurisdiction because Invitae has no contacts in Utah.

Invitae’s motion asserts that although the patent infringement suit by Utah-based Myriad would fail on its merits, the court should dismiss it immediately because it lacks jurisdiction over San Francisco-based Invitae. Invitae argues it cannot be sued in Utah because it does not...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.